Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 08:02 ET | Source: Quantum BioPharma

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a...
March 30, 2026 08:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

Data showed 50% or more of patients reporting >50% improvement in key pain and function scales No adverse events related to dose-limiting toxicities associated with hypoxic-cultured mesenchymal...
March 19, 2026 08:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

New blinded data from ~45 patients to date in key pain and function scales and safety and tolerability of the Company’s proprietary hypoxic-cultured mesenchymal stem cells to be unveiled on March 28th...
September 28, 2023 11:15 ET | Source: Synlogic, Inc.

Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism

CAMBRIDGE, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
January 26, 2023 14:05 ET | Source: BioAegis Therapeutics

BioAegis Therapeutics Announces FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ Gelsolin, for the Treatment of ARDS

NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory diseases through a portfolio built around plasma...
July 21, 2015 09:00 ET | Source: Lingotek

Lingotek and Polylang Announce New Translation Partnership to Enable Translation Inside WordPress

LEHI, UT--(Marketwired - Jul 21, 2015) - Lingotek | The Translation Network, the leader and first cloud-based translation management system and Polylang, the most popular multilingual plugin for...
June 17, 2015 11:00 ET | Source: Lingotek

Aries TCO, Inc. and Lingotek Announce New Translation Integration With Marketo

LEHI, UT--(Marketwired - Jun 17, 2015) - Lingotek | The Translation Network, the leader in cloud-based translation solutions and Aries TCO, Inc., a company focused on Integration, Information...
June 01, 2015 10:00 ET | Source: Lingotek

Lingotek and iTalent Help Lithium Customers Facilitate Translation to Expand Their Global Presence

LEHI, UT--(Marketwired - Jun 1, 2015) - Lingotek | The Translation Network and leader in cloud-based translation solutions, announced today their most recent Lingotek -- Inside integration...
May 11, 2015 09:00 ET | Source: Lingotek

Lingotek Helps Princess Cruises Manage "Translation at Sea"

LEHI, UT--(Marketwired - May 11, 2015) - Princess@Sea is an industry-first, guest-facing, multilingual digital experience platform built on Drupal. In the cruise industry where exotic...
February 03, 2015 09:00 ET | Source: Lingotek

Driven by Demand for Continuous Translation, Lingotek Expands Into EMEA, Grows Sales Force by Three Times

LEHI, UT--(Marketwired - Feb 3, 2015) - Lingotek | The Translation Network is experiencing ongoing momentum in 2015, with the addition of a new EMEA office in London, new sales hires and important...